logo
AAT Bioquest

Stem cell growth factor receptor Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
ImatinibIC50100.0 [1]
SunitinibIC5010.0 [1]
SunitinibKi4.0 [1]
DasatinibIC505.0 [1]
StaurosporineIC504.5 [1]
NilotinibIC50200.0 [1]
CabozantinibIC504.6 [1]
ForetinibIC506.7 [1]
4-Methyl-N-[3-methyl-5-(4-methylimidazol-1-yl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamideIC50200.0 [1]
4-Methyl-N-[3-(4-methylimidazol-1-yl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamideIC50200.0 [1]
N-[3-Fluoro-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamideIC50200.0 [1]
BosutinibIC5032.0 [1], 132.0 [2], 181.0 [3], 2772.0 [4], 6313.0 [5]
SorafenibIC5010.0 [1], 31.0 [2], 68.0 [3]
EllipticineIC50200.0 [1], 10000.0 [2]
DovitinibIC501.0 [1], 1.1 [2], 3.0 [3], 48.3 [4]
ElliptiniumIC5010.0 [1], 400.0 [2]
9-HydroxyellipticineIC5010.0 [1], 400.0 [2]
9-MethoxyellipticineIC50300.0 [1], 500.0 [2], 600.0 [3], 800.0 [4]
1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)ureaIC506.0 [1], 6.03 [2]
DatelliptiumIC5010.0 [1], 300.0 [2], 450.0 [3]
Thienopyrimidine deriv. 11IC508.91 [1], 9.0 [2]
1,3-Propanediamine, N,N-diethyl-N'-(9-methoxy-5-methyl-6H-pyrido(4,3-b)carbazol-1-yl)-IC50400.0 [1], 600.0 [2], 2000.0 [3], 2500.0 [4]
6H-Pyrido(4,3-b)carbazol-9-ol, 1-((3-(diethylamino)propyl)amino)-5,11-dimethyl-IC5010.0 [1], 1200.0 [2], 1400.0 [3]
9-BromoellipticineIC50200.0 [1], 300.0 [2], 10000.0 [3]
N',N'-Diethyl-N-(2-methyl-6,15,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1,3(8),4,6,9,11(16),12,14-octaen-7-yl)propane-1,3-diamineIC50250.0 [1], 300.0 [2], 1900.0 [3], 2300.0 [4]
4-(4-(5-Benzylpyrimidin-2-yl)piperazin-1-yl)quinazolineIC50316.0 [1], 699.0 [2], 2823.0 [3], 10000.0 [4]
PazopanibIC5074.0 [1], 118.0 [2]
VatalanibIC50620.0 [1], 700.0 [2], 730.0 [3]
SemaxanibIC5035.0 [1], 400.0 [2], 660.0 [3]
PonatinibIC501.7 [1], 4.9 [2]
SaracatinibIC50200.0 [1]
LinifanibIC5014.0 [1], 16.0 [2]
Osi-930IC5010.0 [1], 29.0 [2], 80.0 [3]
3-N-[4-(4-Morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamineIC504.0 [1]
3-N-[4-(4-Morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamineKi1.0 [1]
Thienopyrimidine deriv. 20IC5021.88 [1], 22.0 [2]
Thienopyrimidine deriv. 24IC50140.0 [1], 141.25 [2]
Thienopyrimidine deriv. 26IC5019.0 [1], 19.05 [2]
Thienopyrimidine deriv. 88IC5026.92 [1], 27.0 [2]
Thienopyrimidine deriv. 91IC5038.0 [1], 38.02 [2]
Thienopyrimidine deriv. 93IC5028.0 [1], 28.18 [2]
Thienopyrimidine deriv. 10IC5067.61 [1], 68.0 [2]
Thienopyrimidine deriv. 13IC5050.0 [1], 50.12 [2]
Thienopyrimidine deriv. 14IC5019.0 [1], 19.05 [2]
Thienopyrimidine deriv. 15IC5015.0 [1], 15.14 [2]
Thienopyrimidine deriv. 18IC5033.0 [1], 33.11 [2]
Thienopyrimidine deriv. 19IC50109.65 [1], 110.0 [2]
Thienopyrimidine deriv. 21IC5028.84 [1], 29.0 [2]
Thienopyrimidine deriv. 23IC5047.86 [1], 48.0 [2]
Thienopyrimidine deriv. 27IC50173.78 [1], 175.0 [2]
Thienopyrimidine deriv. 28IC50181.97 [1], 182.0 [2]
Thienopyrimidine deriv. 51IC50158.49 [1], 160.0 [2]
Thienopyrimidine deriv. 52IC50398.11 [1], 400.0 [2]
Thienopyrimidine deriv. 53IC50930.0 [1], 933.25 [2]
Thienopyrimidine deriv. 59IC50575.44 [1], 580.0 [2]
Thienopyrimidine deriv. 60IC50794.33 [1], 800.0 [2]
Thienopyrimidine deriv. 79IC5081.28 [1], 82.0 [2]
Thienopyrimidine deriv. 83IC50954.99 [1], 960.0 [2]
Thienopyrimidine deriv. 85IC50360.0 [1], 363.08 [2]
Thienopyrimidine deriv. 87IC50810.0 [1], 812.83 [2]
Thienopyrimidine deriv. 90IC50180.0 [1], 181.97 [2]
Thienopyrimidine deriv. 92IC5053.7 [1], 54.0 [2]
TaxifolinIC5015700.0 [1], 21900.0 [2]
CeritinibIC501280.0 [1], 2855.0 [2]
TandutinibIC50170.0 [1], 220.0 [2]
PectolinarigeninIC50600.0 [1], 1500.0 [2]
Bms-777607IC50144.0 [1], 500.0 [2]
JNJ-28312141 free baseIC505.0 [1], 41.0 [2]
4-[2-(Butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-olIC508.18 [1]
TafetinibIC502.4 [1], 5.0 [2]
2-[2-[4-[4-(4-Tert-butylanilino)phenoxy]-6-methoxyquinolin-7-yl]oxyethylamino]ethanolIC5069.0 [1], 100.0 [2]
3-(2-Aminoquinazolin-6-yl)-4-methyl-1-[4-(1,3-oxazol-2-yl)phenyl]pyridin-2-oneIC5016.0 [1], 22.0 [2]
7,8-Dihydroxy-5,6-dimethoxy-2-phenylchromen-4-oneIC50500.0 [1], 7800.0 [2]
Flt-3 Inhibitor IIIC50500.0 [1]
(2Z)-6-Hydroxy-2-(4-methoxybenzylidene)-1-benzofuran-3(2H)-oneIC501400.0 [1], 15600.0 [2]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)ureaIC5041.0 [1]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-m-tolylureaIC5017.0 [1]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(4-fluoro-3-methylphenyl)ureaIC5010.0 [1]
2-Methyl-N-pyrimidin-5-yl-5-[[3-(trifluoromethyl)benzoyl]amino]benzamideIC5014.0 [1]
N-[4-[4-[[5-Tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]carbamoylamino]anilino]quinazolin-6-yl]propanamideIC5021.9 [1], 155.0 [2]
9-Ethyl-6,6-dimethyl-8-[4-(oxetan-3-yl)piperazin-1-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrileIC505000.0 [1]
Thienopyrimidine deriv. 74IC5028.0 [1], 28.18 [2]
Thienopyrimidine deriv. 12IC5083.0 [1], 83.18 [2]
Thienopyrimidine deriv. 17IC5026.92 [1], 27.0 [2]
Thienopyrimidine deriv. 84IC5037.0 [1], 37.15 [2]
Thienopyrimidine deriv. 86IC5025.7 [1], 26.0 [2]
(1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamineIC5050000.0 [1]
N-(1,3-Benzodioxol-5-ylmethyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamideIC50220.0 [1], 1800.0 [2]
Methanesulfonic acid;N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-(piperazin-1-ylmethyl)benzamideIC50293.0 [1], 342.0 [2]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(3-bromophenyl)ureaIC5069.0 [1]
1-(4-(3-Amino-7-((4-methylpiperazin-1-yl)methyl)-1H-indazol-4-yl)phenyl)-3-m-tolylureaIC50290.0 [1]
1-(4-(3-Amino-7-fluoro-1H-indazol-4-yl)phenyl)-3-m-tolylureaIC505.0 [1]
1-(4-(3-Amino-7-bromo-1H-indazol-4-yl)phenyl)-3-m-tolylureaIC5039.0 [1]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(3-ethylphenyl)ureaIC5042.0 [1]
1-(4-(3-Amino-7-(2-morpholinoethoxy)-1H-indazol-4-yl)phenyl)-3-m-tolylureaIC5050.0 [1]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(3-chlorophenyl)ureaIC5013.0 [1]
1-(4-(3-Amino-7-(2-(2-oxopyrrolidin-1-yl)ethoxy)-1H-indazol-4-yl)phenyl)-3-m-tolylureaIC5053.0 [1]
4-(6,7-Dimethoxy-9H-pyrimido[4,5-b]indol-4-yl)-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]piperazine-1-carbothioamideIC5028000.0 [1]
1-[4-(3-Amino-1H-indazol-4-yl)phenyl]-3-thiophen-3-ylureaIC5042.0 [1]
1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-cyclopentylureaIC50850.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Stem cell growth factor receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Dec2024https://www.aatbio.com/data-sets/stem-cell-growth-factor-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024December 21). Quest Database™ Stem cell growth factor receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/stem-cell-growth-factor-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan